Ai XH - Search Results

1

Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer.

Zhou Z, Chen ZW, Yang XH, Shen L, Ai XH, Lu S, Luo QQ. Zhou Z, et al. Among authors: ai xh. J Exp Clin Cancer Res. 2012 Apr 26;31(1):34. doi: 10.1186/1756-9966-31-34. J Exp Clin Cancer Res. 2012. PMID: 22537906 Free PMC article.

2

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S. Li Z, et al. J Thorac Oncol. 2009 Jun;4(6):702-9. doi: 10.1097/JTO.0b013e3181a5269d. J Thorac Oncol. 2009. PMID: 19404215 Free article.

3

[Genome wide association study on lung cancer.].

Niu X, Ai X, Lu S. Niu X, et al. Zhongguo Fei Ai Za Zhi. 2009 Jul 20;12(7):792-8. doi: 10.3779/j.issn.1009-3419.2009.07.010. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719158 Free article. Chinese. No abstract available.

4

[Advances of maintenance chemotherapy on advanced non-small cell lung cancer.].

Ai X, Lu S. Ai X, et al. Zhongguo Fei Ai Za Zhi. 2008 Feb 20;11(1):14-6. doi: 10.3779/j.issn.1009-3419.2008.01.004. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20727258 Free article. Chinese. No abstract available.

5

[Advances in multimodality therapy of lung cancer].

Ai X, Lu S, Liao M. Ai X, et al. Zhongguo Fei Ai Za Zhi. 2003 Dec 20;6(6):441-3. doi: 10.3779/j.issn.1009-3419.2003.06.07. Zhongguo Fei Ai Za Zhi. 2003. PMID: 21310126 Free article. Chinese. No abstract available.

6

Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.

Yang Y, Zhou Z, Niu XM, Li ZM, Chen ZW, Jian H, Ai XH, Cheng BJ, Liao ML, Lu S. Yang Y, et al. Among authors: ai xh. J Surg Oncol. 2012 Nov;106(6):736-41. doi: 10.1002/jso.23190. Epub 2012 Jun 18. J Surg Oncol. 2012. PMID: 22711667

7

Long-term survival in thymic epithelial tumors: a single-center experience from China.

Shen S, Ai X, Lu S. Shen S, et al. J Surg Oncol. 2013 Feb;107(2):167-72. doi: 10.1002/jso.23256. Epub 2012 Sep 20. J Surg Oncol. 2013. PMID: 22996015

8

A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivity.

Ai X, Sun Y, Wang H, Lu S. Ai X, et al. Amino Acids. 2014 Jul;46(7):1635-48. doi: 10.1007/s00726-014-1716-0. Amino Acids. 2014. PMID: 24658966

9

Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis.

Yang Y, Zhao Y, Ai X, Cheng B, Lu S. Yang Y, et al. Int J Clin Exp Pathol. 2014 Dec 1;7(12):8453-61. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674209 Free PMC article.

10

NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10.

Sun Y, Ai X, Shen S, Lu S. Sun Y, et al. Oncotarget. 2015 Apr 10;6(10):8244-54. doi: 10.18632/oncotarget.3135. Oncotarget. 2015. PMID: 25749519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters